Tuberculosis is caused by Mycobacterium tuberculosis. In 2016, this was the most common causative pathogen for death by infectious diseases. Therefore, investigating the biology of infection and disease development is important in the quest to end tuberculosis. In this study, the authors conducted an integrative analysis of human and pathogen genome variations in tuberculosis. The study is published in Springer Nature's Journal of Human Genetics.
Genome-wide association study (GWAS) is an analysis method in genetics which is used to identify disease-related genome variations by comparing the differences in genotype frequencies in a case and control group. There have been several GWAS regarding susceptibility to tuberculosis. However, previous GWAS have not been based on analysis that accounted for pathogen variations. The possible interplay between the host and pathogen genomic variations is difficult to analyze because both the infected human genome and infecting pathogen genome need to be collected from large numbers of patients. In this research the authors did a systematic exploration of host variations for their association with specific lineages of Mycobacterium tuberculosis, which share the same pathogen genome variations.
This is the first GWAS report identifying the host genetic association with tuberculosis after stratification by pathogen variations. Genotype frequency of a single nucleotide polymorphism (SNP) was increased in a group of patients infected by specific lineage of Mycobacterium tuberculosis compared with the healthy controls. The increased frequency of the SNP was not observed in a group of patients infected by the other lineage, suggesting the pathogen lineage-specific risk of this human genome variant and importance of analyzing the interaction between the host and pathogen genome variants. The identified SNP locates near CD53 gene, encoding a leukocyte surface glycoprotein and known to have functions in immunity and stress response. Increased gene expression of CD53 was observed in active TB patients and supports its biological roles in susceptibility to tuberculosis.
There have been six major lineages reported worldwide (Gagneux S. et al., PNAS 2006). The authors have already reported a strain-dependent association of HLA class II genes in tuberculosis (Toyo-oka L et al., HLA 2017), thus heterogeneity of the pathogen genome may be responsible for the inconsistency of previous genetic association studies for tuberculosis.
"Nearly one third of the world's population are infected by Mycobacterium tuberculosis, but only 10 percent of them show symptoms of TB throughout their life." explains lead author Yosuke Omae. "This research lays the foundations for us to identify who will get TB."
Reference: Omae Y et al. (2017) Pathogen lineage-based genome-wide association study identified CD53 as susceptible locus in tuberculosis. Journal of Human Genetics DOI 10.1038/jhg.2017.82
Source: Springer
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.